A patient who showed a pathologically complete response after undergoing treatment with XELOX plus bevacizumab for synchronous liver metastasis of grade H2 from sigmoid colon cancer.

Hisatsune, Yasuhito; Nakano, Hiroshi; Mihara, Yoshitaka; Tobe, Naotaka; Ishibashi, Kazuyoshi; Shimamura, Tsukasa; Tanaka, Kei-Ichi; Aida, Yoshio; Otsubo, Takehito

Hisatsune, Yasuhito; Nakano, Hiroshi; Mihara, Yoshitaka; Tobe, Naotaka; Ishibashi, Kazuyoshi; Shimamura, Tsukasa; Tanaka, Kei-Ichi; Aida, Yoshio; Otsubo, Takehito.

Afiliación

Hisatsune Y; Department of Gastroenterological Surgery, St. Marianna University Yokohama-City-West Hospital, 1197-1 Yasashi-cho, Asahi-ku, Yokohama, 241-0811, Japan;

J Gastrointest Oncol ; 4(2): E5-E10, 2013 Jun.

Article en En | MEDLINE | ID: mdl-23730524

Palabras clave

XELOX + Bevacizumab; pathological complete response; synchronous colorectal liver metastasis (H2)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Gastrointest Oncol Año: 2013 Tipo del documento: Article Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google